Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 3Neoplasms 2Warts 1Urinary Bladder Neoplasms 1Spinal Cord Neoplasms 1Shock, Septic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion 1Papillomavirus Infections 1Liver Neoplasms 1Depression 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 3lenvatinib 2sintilimab 1pembrolizumab 1halofantrine 1glucose-regulated proteins 1camrelizumab 1Tranexamic Acid 1Thalidomide 1Sunitinib 1Standard of Care 1Saline Solution 1Oxaliplatin 1Nadroparin 1Lidocaine 1Injections 1Immune Checkpoint Inhibitors 1Heparin, Low-Molecular-Weight 1Gemcitabine 1Folfox protocol 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Liver Neoplasms × Saline Solution × Clear all
NCT05153785 2026-01-15

Perioperative Intravenous Lidocaine in Liver Surgery

Lund University Hospital

Phase 2/3 Completed
124 enrolled
Gastrointestinal

Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡